Skadden represented Pfizer Inc. in its successful motion to dismiss RICO claims brought by Health Care Service Corporation alleging Pfizer improperly promoted off-label use for the drug Bextra. On August 2, Judge Charles Breyer of the U. S. District Court for the Northern District of California dismissed HCSC's claims with prejudice.
Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates